PlainRecalls
FDA Drug Moderate Class II Ongoing

OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10

Reported: December 24, 2025 Initiated: October 31, 2025 #D-0234-2026

Product Description

OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10

Reason for Recall

Defective container: cracked/broken cartridges

Details

Units Affected
1,636 cartons
Distribution
U.S.A. Nationwide
Location
Cambridge

Frequently Asked Questions

What product was recalled?
OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10. Recalled by Novocol Pharmaceutical of Canada, Inc.. Units affected: 1,636 cartons.
Why was this product recalled?
Defective container: cracked/broken cartridges
Which agency issued this recall?
This recall was issued by the FDA Drug on December 24, 2025. Severity: Moderate. Recall number: D-0234-2026.